XJPX
7634
Market cap98mUSD
Oct 09, Last price
5,030.00JPY
1D
1.31%
1Q
2.65%
Jan 2017
36.50%
IPO
178.95%
Name
Hoshi Iryo-Sanki Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hoshi Iryo-Sanki Co., Ltd., a Japanese firm, specializes in the production and distribution of pharmaceutical-grade medical oxygen and nitrous oxide. Its business activities are structured across five distinct divisions: Medical Gas, Home Healthcare, Medical Gas Equipment Construction, Nursing Care, and Facilities Nursing. The Medical Gas division primarily handles the sale of various medical gases, including oxygen and anesthetic gases. Through its Home Healthcare division, the company offers rental services for essential medical devices, such as oxygen concentrators for home therapy, continuous positive airway pressure (CPAP) machines, and home ventilators. The Medical Gas Equipment Construction segment is responsible for the planning, installation, and subsequent maintenance and inspection of medical gas piping systems. The Nursing Care division provides a comprehensive suite of services, encompassing the rental and sale of care-related products, home modifications, and direct nursing assistance through home visits and in-home care coordination. Lastly, the Facilities Nursing division manages and operates fee-based residential nursing homes and day care centers, along with other related services. Established in 1960, the company's main offices are situated in Tokyo, Japan.
Key people
Yukio Hoshi
President, Representative Director · since 2005
Hikaru Hoshi
Executive Officer, Director of Finance · since 2024
Masahiro Hoshi
Senior Managing Director, Manager of President's Office · since 2005
Yukio Mogaki
Senior Managing Director, Chief Director of Administration, Director of Purchasing, President of Subsidiary · since 2024
Mitsuo Nukagari
Managing Director, Chief Director of Sales · since 2024
Tadashi Hasegawa
Executive Officer, Manager of Okayama Block · since 2024
Toru Hoshi
Executive Officer, Chief Director of Business Strategy · since 2024
Nobuyoshi Kataoka
Executive Officer, Director of General Affairs · since 2022
Koichi Okita
Executive Officer, Manager of Tokyo and South Tokyo Block · since 2024
Kazuo Saito
Executive Officer, Director of Medical Gas Business · since 2022
Kazuhiro Hayamizu
Director of Medical Equipment Business, Director · since 2017
Yasuyuki Suzuki
Manager of Nagoya Office, Director · since 2014
Masanari Hoshi
Chairman of the Board · since 2014
Daisuke Tokunaga
Director · since 2023
Independent Director · since 2021
Yuichi Yagi
Independent Director · since 2019
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||